Sam Chun Dang Pharm. Co., Ltd
000250.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
158
Cost of Revenue
83
Gross Profit
75
Gross Margin
47.3%
Operating Income
2
Operating Margin
1.3%
Net Income
-8
Net Margin
-5.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
15
EBITDA Margin
9.7%
2023
12/31/2023
Revenue
145
Cost of Revenue
72
Gross Profit
73
Gross Margin
50.3%
Operating Income
7
Operating Margin
5.0%
Net Income
-8
Net Margin
-5.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
5
EBITDA Margin
3.4%
2022
12/31/2022
Revenue
133
Cost of Revenue
67
Gross Profit
66
Gross Margin
49.6%
Operating Income
9
Operating Margin
7.1%
Net Income
4
Net Margin
3.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
15
EBITDA Margin
10.9%
2021
12/31/2021
Revenue
125
Cost of Revenue
65
Gross Profit
61
Gross Margin
48.6%
Operating Income
-11
Operating Margin
-9.1%
Net Income
-12
Net Margin
-9.9%
EPS (Basic)
$-1.00
EPS (Diluted)
$-1.00
EBITDA
-8
EBITDA Margin
-6.5%
2020
12/31/2020
Revenue
125
Cost of Revenue
56
Gross Profit
69
Gross Margin
55.5%
Operating Income
3
Operating Margin
2.3%
Net Income
-1
Net Margin
-0.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
18
EBITDA Margin
14.3%